A Safety Study of 212Pb-Pentixather Radioligand Therapy

NCT05557708 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Carcinoid Tumor Lung
Neuroendocrine Tumor of the Lung
Carcinoma, Small-Cell Lung

Interventions

DRUG: 212-Lead Pentixather
DIAGNOSTIC_TEST: 203-Lead Pentixather SPECT/CT

Sponsor

Yusuf Menda

Collaborators

[object Object]
[object Object]
[object Object]